Update on diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Area of Science:

• Pulmonary Medicine
• Oncology
• Rare Lung Diseases

Background:

• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare lung disorder.
• Characterized by neuroendocrine cell hyperplasia, tumorlets, and tumors.
• Often misdiagnosed as asthma, presenting with lung nodules, chronic cough, and airflow obstruction.

Purpose of the Study:

• Increase awareness of DIPNECH among pulmonary clinicians.
• Highlight the importance of recognizing DIPNECH due to increased lung nodule detection via CT scans.
• Provide an overview of recent clinical experiences and management principles.

Main Methods:

• Review of retrospective case series and recent clinical experiences from academic centers.
• Analysis of diagnostic presentations, including pulmonary function tests (PFTs).
• Discussion of imaging modalities like DOTATATE scans and somatostatin analog efficacy.

Main Results:

• Evidence base for DIPNECH is limited but growing.
• Clinical presentations vary, including dyspnea and restrictive PFT patterns.
• Variability exists in diagnosis and management approaches.

Conclusions:

• Enhanced clinician awareness of DIPNECH is essential.
• Multidisciplinary assessment aids in guiding patient management.
• Multicenter collaboration is needed to establish best practices for DIPNECH.